SNOA
NASDAQ · Pharmaceuticals
Sonoma Pharmaceuticals Inc
$1.26
+0.01 (+0.80%)
Open$1.28
Previous Close$1.25
Day High$1.28
Day Low$1.26
52W High$4.60
52W Low$0.85
Volume—
Avg Volume47.9K
Market Cap6.03M
P/E Ratio—
EPS$-1.22
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+926.2% upside
Current
$1.26
$1.26
Target
$12.93
$12.93
$7.21
$12.93 avg
$14.12
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 54.66M | 48.06M | 1.82M |
| Net Income | -8,887,033 | -7,031,498 | 463.1K |
| Profit Margin | -16.3% | -15.5% | 25.4% |
| EBITDA | -6,499,591 | -5,428,229 | 609.2K |
| Free Cash Flow | — | — | 381.4K |
| Rev Growth | +13.8% | +13.8% | -7.1% |
| Debt/Equity | 0.07 | 0.07 | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |